Researcher
Erika Vlieghe
- Keywords (University of Antwerp):Medicine
- Disciplines (University of Antwerp):Diagnostics, Immunology, Intensive care and emergency medicine, Laboratory medicine, Medical systems biology, Microbiology, Respiratory medicine, Tropical medicine, Other clinical sciences, Nursing
- See also: E Vlieghe (Institute of Tropical Medicine)
Affiliations
- Department of Clinical Sciences, Management (Research unit)
Member
From1 May 2019 → Today - Department of Clinical Sciences, Management (Research unit)
Member
From1 May 2019 → 25 Feb 2022 - Medical Services (Research unit)
Member
From1 May 2019 → 21 Apr 2021 - Global Health Institute (GHI) (Research group)
Member
From1 Jan 2019 → Today - Epidemiology and social medicine (ESOC) (Research group)
Member
From1 Feb 2017 → 31 Dec 2018 - Tropical Bacteriology (Research unit)
Member
From1 Aug 2004 → 5 Sep 2013 - Tropical Medicine (Research unit)
Member
From1 Aug 2004 → 25 May 2012
Projects
1 - 4 of 4
- Preparing First Line health care workers in the Flemish health care system for 'virus X', by setting up and validating a training package, using viral hemorrhagic fever as a model (FiLi-Vi-X).From1 May 2023 → TodayFunding: Flemish Resilience. Government of Flanders Recovery Plan - strengthening R&D
- Data-driven implementation of a behavioural Antimicrobial Stewardship approach and expert consultancy for a more appropriate use of antimicrobials in Europe (DRIVE-AMS).From1 Nov 2022 → TodayFunding: Other EU initiatives out of framework
- Infectious Diseases Education Advanced Level Intensive Training for a nEw Reality (IDEALiTER)From1 Oct 2022 → TodayFunding: Other EU initiatives out of framework
- Antimicrobial Resistance, Prescribing, and Consumption Data to Inform Country Antibiotic Guidance and Local Action (ADILA).From1 Apr 2022 → TodayFunding: Foreign public sponsor
Publications
1 - 10 of 90
- The combined effect of systemic antibiotics and proton pump inhibitors on Clostridioides difficile infection and recurrence(2024)
Authors: Nele Moreels, Annelies Boven, Oswaldo Gressani, Fredrik L. Andersson, Erika Vlieghe, Steven Callens, Lars Engstrand, Johanna Simin, Nele Brusselaers
Pages: 608 - 616 - Diagnosing viral infections through T cell receptor sequencing of activated CD8+ T cells(2024)
Authors: Alexandra Vujkovic, My Ha, Tessa de Block, Lida van Petersen, Isabel Brosius, Caroline Theunissen, Sabrina van Ierssel, Esther Bartholomeus, Wim Adriaensen, Guido Vanham, et al.
Pages: 507 - 516 - Implementation of the advanced HIV disease care package with point-of-care CD4 testing during tuberculosis case finding(2023)
Authors: Tinne Gils, Mashaete Kamele, Thandanani Madonsela, Shannon Bosman, Thulani Ngubane, Philip Joseph, Klaus Reither, Moniek Bresser, Erika Vlieghe, Tom Decroo, et al.
Pages: 1 - 18 - Leveraging T-cell receptor – epitope recognition models to disentangle unique and cross-reactive T-cell response to SARS-CoV-2 during COVID-19 progression/resolution(2023)
Authors: Anna Postovskaya, Alexandra Vujkovic, Tessa de Block, Lida van Petersen, Maartje van Frankenhuijsen, Isabel Brosius, Emmanuel Bottieau, Christophe Van Dijck, Caroline Theunissen, Sabrina van Ierssel, et al.
Pages: 1 - 14 - Strongyloides stercoralis in the non-endemic setting and beyond(2023)
Authors: Dora Buonfrate, Erika Vlieghe, Emmanuel Bottieau
Number of pages: 181 - Clostridioides difficile infection-associated cause-specific and all-cause mortality(2023)
Authors: Annelies Boven, Erika Vlieghe, Lars Engstrand, Fredrik L. Andersson, Steven Callens, Nele Brusselaers
Pages: 1424 - 1430 - Pandemics and other health crises(2022)
Authors: Gianluca Quaglio, Luca Ragazzoni, Isabel De la Mata, Raed Arafat, Sabine De Muynck, Erika Vlieghe, Petra Claes
Pages: 827 - 831 - Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease(2022)
Authors: M. Linschoten, A. Uijl, A. Schut, C.E.M. Jakob, L.R. Romao, R.M. Bell, E. McFarlane, M. Stecher, A.G.M. Zondag, E.P.A. van Iperen, et al.
Pages: 1104 - 1120 - Activation of the carboxypeptidase U (CPU, TAFIa, CPB2) system in patients with SARS-CoV-2 infection could contribute to COVID-19 hypofibrinolytic state and disease severity prognosis(2022)
Authors: Karen Claesen, Yani Sim, An Bracke, Michelle De bruyn, Emilie De Hert, Gwendolyn Vliegen, An Hotterbeekx, Alexandra Vujkovic, Lida van Petersen, Fien De Winter, et al.
Pages: 1 - 11 - Use of WATCH antibiotics prior to presentation to the hospital in rural Burkina Faso(2022)
Authors: Daniel Valia, Brecht Ingelbeen, Berenger Kabore, Ibrahima Karama, Marjan Peeters, Palpouguini Lompo, Erika Vlieghe, Annelies Post, Janneke Cox, Quirijn de Mast, et al.
Pages: 1 - 7